ACORDA THERAPEUTICS INC's ticker is ACOR and the CUSIP is 00484M106. A total of 162 filers reported holding ACORDA THERAPEUTICS INC in Q4 2017. The put-call ratio across all filers is 1.84 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $0 | – | 60 | 0.0% | 0.00% | – |
| Q2 2020 | $0 | – | 60 | 0.0% | 0.00% | – |
| Q1 2020 | $0 | – | 60 | -25.9% | 0.00% | – |
| Q4 2019 | $0 | – | 81 | 0.0% | 0.00% | – |
| Q3 2019 | $0 | -100.0% | 81 | -22.9% | 0.00% | -100.0% |
| Q2 2019 | $3,000 | +200.0% | 105 | +32.9% | 0.00% | – |
| Q1 2019 | $1,000 | 0.0% | 79 | 0.0% | 0.00% | – |
| Q4 2018 | $1,000 | 0.0% | 79 | +31.7% | 0.00% | – |
| Q3 2018 | $1,000 | -66.7% | 60 | -42.9% | 0.00% | -100.0% |
| Q2 2018 | $3,000 | +200.0% | 105 | +75.0% | 0.00% | – |
| Q1 2018 | $1,000 | 0.0% | 60 | -91.6% | 0.00% | – |
| Q4 2017 | $1,000 | – | 717 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PFM Health Sciences, LP | 1,526,174 | $1,423,000 | 0.12% |
| GSA CAPITAL PARTNERS LLP | 250,271 | $233,000 | 0.06% |
| Spark Investment Management LLC | 110,300 | $102,000 | 0.05% |
| SALZHAUER MICHAEL | 30,000 | $28,000 | 0.05% |
| HAP Trading, LLC | 260,800 | $532,000 | 0.04% |
| Point72 Asset Management, L.P. | 1,589,600 | $1,482,000 | 0.01% |
| DLD Asset Management, LP | 208,400 | $196,000 | 0.01% |
| ACADIAN ASSET MANAGEMENT LLC | 1,893,678 | $1,765,000 | 0.01% |
| EVERENCE CAPITAL MANAGEMENT INC | 65,680 | $61,000 | 0.01% |
| Benin Management CORP | 11,714 | $11,000 | 0.01% |